Aberdeen Investments: Chinese innovation is underappreciated by the market
Markets have overly punished China equities with long-term innovation drivers, according to Aberdeen Investment’s Nicholas Yeo.
RQI applies a research-driven, quantitative investment process to analyse a broad universe of companies.
This week, FSA compares the Robeco Smart Energy fund and the Pictet Clean Energy Transition fund.
The manager has switched the benchmark to the MSCI Emerging Markets 10/40 Index.
Cameron Chui succeeds Timothy Fung in the role.
The Macro Opportunities Strategy is a daily dealing, Luxembourg domiciled investment vehicle.
The fund aims to seek growth from China’s structural transformation.
US value indices are now full of mega-cap tech names.
The deal provides Citi HK’s retail clients access to the Wellington Asia Technology fund.
However, fixed-income funds saw outflows as rising bond yields hurt returns.
Asia-Pacific was particularly strong, with core growth of 13.3% led by Taiwanese tech companies and Australian miners.
The fund will aim to invest in 100-200 stocks.
FSA highlights 5 healthcare exchange-traded-funds that are outpacing the S&P 500 index year-to-date.
Hang Seng Bank has onboarded the BNP Paribas Asset Management funds to its wealth management platform.
This week FSA compares two UK equities funds: MFS Meridian UK Equity fund and the Schroder ISF UK Equity fund.
Schroders is calling for investors to look beyond dominant market themes to identify businesses whose long-term prospects may not be adequately reflected in their share prices.
Combining dividend-paying equities, sovereign bonds and structured products can help generate resilient income while reducing portfolio concentration risks, believes Templeton Global Investments.